StempeucelOA™, mesenchymal stem cells for treatment of osteoarthritis

Stempeucel is comprised of autologous, ex vivo-expanded bone marrow-derived mesenchymal stem cells. This study aims to assess the safety and tolerability of a single dose of intraarticularly injected Stempeucel in patients with osteoarthritis of the knee.